Subtopic Deep Dive
Glutamine Metabolism in Cancer
Research Guide
What is Glutamine Metabolism in Cancer?
Glutamine metabolism in cancer refers to the elevated glutaminolysis in tumor cells, where glutamine is converted to glutamate by glutaminase (GLS1) to fuel TCA cycle anaplerosis, redox balance, and nucleotide/lipid synthesis beyond aerobic glycolysis.
Tumor cells exhibit glutamine addiction to support rapid proliferation, with excess glutamine uptake exceeding needs for protein and nucleotide synthesis (DeBerardinis et al., 2007; 2546 citations). This process involves GLS1-mediated glutaminolysis, generating α-ketoglutarate for TCA cycle replenishment and aspartate for nucleotides. Over 10 papers from the list highlight glutamine's role in transformed cell metabolism.
Why It Matters
Glutamine metabolism sustains cancer growth by providing carbons for biosynthesis and NADPH for redox homeostasis, enabling survival under hypoxia and oxidative stress (DeBerardinis et al., 2007; Weinberg et al., 2010). Targeting GLS1 inhibitors disrupts this pathway, enhancing chemotherapy efficacy in glutamine-dependent tumors like KRAS-driven cancers. Martínez-Reyes and Chandel (2020) link TCA metabolites from glutamine to disease progression, informing precision therapies.
Key Research Challenges
Quantifying Glutaminolysis Flux
Measuring glutamine flux through GLS1 in vivo remains difficult due to rapid turnover and isotope dilution in tumors. DeBerardinis et al. (2007) used 13C-tracing to show excess glutaminolysis, but spatial heterogeneity complicates assessments. Current tracers underestimate mitochondrial contributions.
Redox Balance in Hypoxia
Glutamine supports NADPH production for ROS detoxification, but hypoxia alters this balance in proliferating cells. Weinberg et al. (2010) demonstrated mitochondrial ROS from glutamine oxidation drives Kras tumorigenicity. Balancing therapy-induced ROS without toxicity is unresolved.
Combination Therapy Resistance
GLS1 inhibitors face resistance via adaptive metabolism shifts to glucose or lipids. Hayes et al. (2020) note oxidative stress responses bypass glutamine blockades. Identifying biomarkers for patient stratification lacks validated models.
Essential Papers
Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
Ralph J. DeBerardinis, Anthony Mancuso, Evgueni Daikhin et al. · 2007 · Proceedings of the National Academy of Sciences · 2.5K citations
Tumor cell proliferation requires rapid synthesis of macromolecules including lipids, proteins, and nucleotides. Many tumor cells exhibit rapid glucose consumption, with most of the glucose-derived...
Mitochondrial TCA cycle metabolites control physiology and disease
Inmaculada Martínez‐Reyes, Navdeep S. Chandel · 2020 · Nature Communications · 2.5K citations
Oxidative Stress in Cancer
John D. Hayes, Albena T. Dinkova‐Kostova, Kenneth D. Tew · 2020 · Cancer Cell · 2.3K citations
ROS in cancer therapy: the bright side of the moon
Bruno Perillo, Marzia Di Donato, Antonio Pezone et al. · 2020 · Experimental & Molecular Medicine · 2.0K citations
Metabolic reprogramming in macrophages and dendritic cells in innate immunity
Beth Kelly, Luke O'neill · 2015 · Cell Research · 1.7K citations
Activation of macrophages and dendritic cells (DCs) by pro-inflammatory stimuli causes them to undergo a metabolic switch towards glycolysis and away from oxidative phosphorylation (OXPHOS), simila...
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Frank Weinberg, Robert B. Hamanaka, William W. Wheaton et al. · 2010 · Proceedings of the National Academy of Sciences · 1.7K citations
Otto Warburg's theory on the origins of cancer postulates that tumor cells have defects in mitochondrial oxidative phosphorylation and therefore rely on high levels of aerobic glycolysis as the maj...
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
Richard Possemato, Kevin M. Marks, Yoav D. Shaul et al. · 2011 · Nature · 1.7K citations
Reading Guide
Foundational Papers
Start with DeBerardinis et al. (2007; 2546 citations) for core glutaminolysis discovery, then Weinberg et al. (2010; 1697 citations) for mitochondrial ROS links.
Recent Advances
Martínez-Reyes and Chandel (2020; 2474 citations) on TCA control; Hayes et al. (2020; 2326 citations) on oxidative stress integration.
Core Methods
13C-isotope tracing for flux (DeBerardinis et al., 2007); functional genomics RNAi screens (Possemato et al., 2011); ROS assays in Kras models (Weinberg et al., 2010).
How PapersFlow Helps You Research Glutamine Metabolism in Cancer
Discover & Search
PapersFlow's Research Agent uses searchPapers and citationGraph to map glutamine metabolism literature starting from DeBerardinis et al. (2007; 2546 citations), revealing 2506 citing papers on glutaminolysis. exaSearch uncovers hypoxia-glutamine links, while findSimilarPapers identifies GLS1 inhibitor studies.
Analyze & Verify
Analysis Agent employs readPaperContent on DeBerardinis et al. (2007) to extract 13C-tracing flux data, then runPythonAnalysis with NumPy/pandas to model glutaminolysis rates from abstracts. verifyResponse (CoVe) and GRADE grading confirm claims like excess glutamine use, with statistical verification of citation impacts.
Synthesize & Write
Synthesis Agent detects gaps in GLS1-redox research via contradiction flagging across Weinberg et al. (2010) and Martínez-Reyes and Chandel (2020). Writing Agent uses latexEditText, latexSyncCitations for DeBerardinis (2007), and latexCompile to generate pathway diagrams; exportMermaid visualizes glutaminolysis-TCA flux.
Use Cases
"Analyze glutamine flux data from DeBerardinis 2007 with Python stats"
Research Agent → searchPapers('DeBerardinis glutamine 2007') → Analysis Agent → readPaperContent → runPythonAnalysis (pandas to compute flux ratios, matplotlib TCA plot) → statistical summary of excess metabolism.
"Write LaTeX review on GLS1 inhibitors in glutamine-addicted cancers"
Synthesis Agent → gap detection (post-DeBerardinis papers) → Writing Agent → latexEditText (draft section) → latexSyncCitations (add Weinberg 2010) → latexCompile → PDF with glutaminolysis figure.
"Find code for modeling cancer glutamine metabolism"
Research Agent → searchPapers('glutamine cancer model') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → runnable Python simulator for GLS1 flux.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ glutamine papers via citationGraph from DeBerardinis (2007), outputting structured report on GLS1 therapies. DeepScan applies 7-step analysis with CoVe checkpoints to verify redox claims in Weinberg et al. (2010). Theorizer generates hypotheses on glutamine-hypoxia synergies from TCA papers.
Frequently Asked Questions
What defines glutamine metabolism in cancer?
Elevated glutaminolysis via GLS1 converts glutamine to glutamate for TCA anaplerosis, exceeding protein/nucleotide needs (DeBerardinis et al., 2007).
What methods study glutamine flux?
13C-glutamine tracing quantifies mitochondrial incorporation; flux exceeds biosynthesis requirements (DeBerardinis et al., 2007; Weinberg et al., 2010).
What are key papers?
DeBerardinis et al. (2007; 2546 citations) shows excess glutaminolysis; Weinberg et al. (2010; 1697 citations) links to ROS/tumorigenicity.
What open problems exist?
Resistance to GLS1 inhibitors via metabolic rewiring; need for hypoxia-specific biomarkers (Hayes et al., 2020; Martínez-Reyes and Chandel, 2020).
Research Cancer, Hypoxia, and Metabolism with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Glutamine Metabolism in Cancer with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers
Part of the Cancer, Hypoxia, and Metabolism Research Guide